96734 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof Linear peptides containing at least one abnormal peptide link
POLYPEPTIDE COMPOUND, AND COMPLEX AND USE THEREOF
#2NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#3SYNTHETIC CATIONIC PEPTIDOMIMETICS, THEIR DERIVATIVES AND PREPARATION THEREOF ALONG WITH COMPOSITIONS FOR VARIOUS MEDICAL APPLICATIONS
#4METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
#5AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#6BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP
#7PROTEASE INHIBITORS
#8IMMUNITY-ENHANCING PEPTIDE ANALOGS AND USES THEREOF
#9PSMA-TARGETED NIR DYES AND THEIR USES
#10NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#11ENZYMATICALLY FORMING INTRANUCLEAR PEPTIDE ASSEMBLIES FOR SELECTIVELY KILLING INDUCED PLURIPOTENT STEM CELLS
#12TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
#13INTERLEUKIN-1 RECEPTOR MODULATORS AND USES THEREOF
#14ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES
#15SMALL PEPTIDE COMPOSITIONS AND USES THEREOF
#16NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#17COMPOSITIONS AND METHODS COMPRISING SPLICING-DERIVED ANTIGENS FOR TREATING CANCER
#18Antibody-Drug Conjugates Comprising an Anti-BCMA Antibody
#19TREATMENT OF SKIN DISORDERS
#20IMPROVED CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY
#21Bicyclic peptide ligands specific for MT1-MMP
#22PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS
#23CASTRATION RESISTANT PROSTATE CANCER
#24PREPARATION AND PURIFICATION PROCESS OF MONOMETHYL AURISTAIN E COMPOUND
#25COMPOSITIONS AND METHODS FOR TREATING A DISEASE
#26NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#27ICD PEPTIDE AND USE THEREOF FOR HAVING CYTOTOXIC ACTIVITY ON CANCER CELLS
#28NOVEL PEPTOID COMPOUNDS THAT BIND TO CELL RECEPTOR ACE2 AND PREVENT VIRUS ENTRY INTO CELLS
#29F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer
#30NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#31PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#32PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#33PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#34NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#35Biologically active compounds
#36NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#37NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#38NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#39NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#40NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#41STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION
#42DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#43COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#44Cyclic polypeptides for PCSK9 inhibition
#45PEPTIDE-BASED COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
#46HLA TUMOR ANTIGEN PEPTIDES OF CLASS I AND II FOR TREATING MAMMARY/BREAST CARCINOMAS
#47KRAS G12V Mutant Binds to JAK1, Inhibitors, Pharmaceutical Compositions, and Methods Related Thereto
#48NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#49Small peptide compositions and uses thereof
#50MODIFIED PEPTIDES AND THEIR USE
#51B-CATENIN/B-CELL LYMPHOMA 9 PROTEIN-PROTEIN INTERACTION INHIBITING PEPTIDOMIMETICS
#52AAV9 affinity agents
#53Peptides and combination of peptides for use in immunotherapy against various tumors
#54NRP-1 BINDING INHIBITORY PEPTIDES AND USES THEREOF
#55SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME
#56PSMA-TARGETED NIR DYES AND THEIR USES
#57Cyclic polypeptides for PCSK9 inhibition
#58SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS
#59Peptide linker and combination for prodrugs activated by prostate-specific antigen
#60NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#61Peptides and combination of peptides for use in immunotherapy against various tumors
#62Peptides and combination of peptides for use in immunotherapy against various tumors
#63Peptides and combination of peptides for use in immunotherapy against various tumors
#64Bicyclic peptide ligands specific for MT1-MMP
#65Peptides and combination of peptides for use in immunotherapy against various tumors
#66Peptides and combination of peptides for use in immunotherapy against various tumors
#67Peptides and combination of peptides for use in immunotherapy against various tumors
#68Peptides and combination of peptides for use in immunotherapy against various tumors
#69Peptides and combination of peptides for use in immunotherapy against various tumors
#70Peptides and combination of peptides for use in immunotherapy against various tumors
#71Peptides and combination of peptides for use in immunotherapy against various tumors
#72Peptides and combination of peptides for use in immunotherapy against various tumors
#73Peptides and combination of peptides for use in immunotherapy against various tumors
#74Peptides and combination of peptides for use in immunotherapy against various tumors
#75Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#76Heteroaryl sulfone-based conjugation handles, methods for their preparation, and their use in synthesizing antibody drug conjugates
#77SELF-STABILIZING LINKER CONJUGATES
#78METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
#79MONOTHIOETHER CROSSLINKERS IN POLYMERS AND APPLICATIONS THEREOF
#80HIF-1 and HIF-2 inhibitors
#81Peptides and combination of peptides for use in immunotherapy against various tumors
#82Peptides and combination of peptides for use in immunotherapy against various tumors
#83Insect, tick, and mite repellent derived from
#84Peptides and combination of peptides for use in immunotherapy against various tumors
#85Multifunction cyclic peptide polymer nanomaterials
#86Peptides for dry eye disease
#87HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF
#88DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#89COMPOSITIONS AND METHODS FOR THE SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS
#90Compounds and methods for reducing or inhibiting aggregation of proteins in a subject
#91ANTIFOLATE CONJUGATES FOR TREATING INFLAMMATION
#9218F - TAGGED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND THEIR USE AS IMAGING AGENTS FOR PROSTATE CANCER
#93PSMA-targeted NIR dyes and their uses
#94Peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient
#95Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#96Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#97Peptides with anti-cancer activity
#98Structure-based peptide inhibitors of α-synuclein aggregation
#99Process for the preparation of drug linker compounds
#100Peptidic materials that traffic efficiently to the cell cytosol and nucleus
#101Biologically active compound conjugated to a stapled or stitched peptide
#102MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDS
#103COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#104Peptides and combination of peptides for use in immunotherapy against various tumors
#105Peptides and combination of peptides for use in immunotherapy against various tumors
#106Bicyclic peptide ligands specific for MT1-MMP
#107Compositions and methods for treating cardiovascular disease
#108Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)
#109Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#110Peptide-oligourea hybrid compounds
#111Castration resistant prostate cancer
#112Compounds for the treatment of neurodegenerative diseases
#113Dual-enzyme responsive peptides
#114NEMO coiled coil mimics and methods of using same
#115Cytotoxin and conjugate, uses of same and preparation method therefor
#116Bicyclic peptide ligands specific for MT1-MMP
#117PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE
#118Small molecule DCN1 inhibitors and therapeutic methods using the same
#119Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#120Relaxin1 derived peptides for use in immunotherapy
#121Peptides and combination of peptides for use in immunotherapy against various tumors
#122Peptides and combination of peptides for use in immunotherapy against various tumors
#123Peptides and combination of peptides for use in immunotherapy against various tumors
#124Growth Hormone Releasing Peptides
#125Binding compound and uses thereof
#126DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#127Zinc-binder based EBNA1-specific compounds
#128Cytotoxic peptides and conjugates thereof
#129Peptide-linked ester prodrugs activated by prostate-specific antigen
#130ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDES
#131Peptoid compound, and derivative, salt, preparation method and use thereof
#132SNAP25 antisense oligonucleotides
#133Monomethylvaline compounds capable of conjugation to ligands
#134EXON SKIPPING BY PEPTIDE NUCLEIC ACID DERIVATIVES
#135Template-directed PNA synthesis process and PNA targeting compounds
#136Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#137Peptoid affinity ligands
#138Peptides and combination of peptides for use in immunotherapy against various tumors
#139Site-specific chemoenzymatic protein modifications
#140Small peptide compositions and uses thereof
#141TRIAZOLE-CROSSLINKED AND THIOETHER-CROSSLINKED PEPTIDOMIMETIC MACROCYCLES
#142Inhibitor-functionalized ultrasmall nanoparticles and methods thereof
#143Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#144Nucleic acid-peptide capsule complexes
#145Structure-based peptide inhibitors of alpha-synuclein aggregation
#146Synthetic peptide amides
#147Compounds for the treatment of neurodegenerative diseases
#148Cyclic peptides and uses thereof
#149NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#150AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#151Compositions and methods for treating cardiovascular disease
#152PSMA-targeted NIR dyes and their uses
#153Insect, tick, and mite repellent derived from
#154NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#155Peptides and combination of peptides for use in immunotherapy against various tumors
#156Compounds, linker-drugs and ligand-drug conjugates
#157Peptoid affinity ligands
#158Peptides with anti-cancer activity
#159AZA-PEPTIDE ALDEHYDES AND KETONES
#160Somatostatin receptor antagonist compounds and methods of using the same
#161HIF-1 and HIF-2 inhibitors
#162Peptides and combination of peptides for use in immunotherapy against various tumors
#163Compositions and methods of using islet neogenesis peptides and analogs thereof
#164Method for synthesizing etelcalcetide
#165Peptides and combination of peptides for use in immunotherapy against various tumors
#166Quinstatin compounds
#167Skin treatment devices and methods with pre-stressed configurations
#168MONOMETHYLVALINE COMPOUNDS HAVING PHENYLALANINE SIDE-CHAIN MODIFICATIONS AT THE C-TERMINUS
#169Peptides and combination of peptides for use in immunotherapy against various tumors
#170Peptides and combination of peptides for use in immunotherapy against various tumors
#171NPR-B agonists
#172NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#173Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#174Bicyclic peptide ligands specific for MT1-MMP
#175HYDROPHILIC SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF
#176RELAXIN1 derived peptides for use in immunotherapy against various tumors
#177Peptides and combination of peptides for use in immunotherapy against various tumors
#178NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#179γ-AA-peptide STAT3/DNA inhibitors and methods of use
#180Foldamer helix bundle-based molecular encapsulation
#181Cytotoxic peptides and conjugates thereof
#182Protein-polymer-drug conjugates
#183Peptides and combination of peptides for use in immunotherapy against various tumors
#184Peptides and combination of peptides for use in immunotherapy against various tumors
#185Peptides and combination of peptides for use in immunotherapy against various tumors
#186Peptides and combination of peptides for use in immunotherapy against various tumors
#187DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#188Peptides and combination of peptides for use in immunotherapy against various tumors
#189Peptides and combination of peptides for use in immunotherapy against various tumors
#190Hydrogel-forming peptides
#19118F—tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer
#192SELF-STABILIZING LINKER CONJUGATES
#193Peptides and combination of peptides for use in immunotherapy against various tumors
#194Derivatives of dolastatin 10 and uses thereof
#195Monomethylvaline compounds capable of conjugation to ligands
#196Peptides and combination of peptides for use in immunotherapy against various tumors
#197Peptides and combination of peptides for use in immunotherapy against various tumors
#198Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#199Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#200PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR UREMIC PRURITUS IN DIALYSIS PATIENTS
#201Peptides and combination of peptides for use in immunotherapy against various tumors
#202NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#203Peptides and combination of peptides for use in immunotherapy against various tumors
#204Peptides and combination of peptides for use in immunotherapy against various tumors
#205Peptides and combination of peptides for use in immunotherapy against various tumors
#206Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#207Compounds, linker-drugs and ligand-drug conjugates
#208COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#209Growth Hormone Releasing Peptides
#210Methods for synthesizing α4β7 peptide antagonists
#211PSMA—targeted NIR dyes and their uses
#212Peptides and combination of peptides for use in immunotherapy against various tumors
#213NPR-B agonists
#214Peptides and combination of peptides for use in immunotherapy against various tumors
#215NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#216PSMA-targeted NIR dyes and their uses
#217Conjugates of pH Low Insertion Peptide and Monomethyl Auristatins in the Treatment of Solid Tumors
#218Heat insulation material based on aerogel
#219TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
#220Antibacterial antisense oligonucleotide and method
#221Peptides and combination of peptides for use in immunotherapy against various tumors
#222Peptides and combination of peptides for use in immunotherapy against various tumors
#223Peptides and combination of peptides for use in immunotherapy against various tumors
#224Antibody-drug conjugate (ADC) and method for forming the same
#225Gamma-AA-peptide STAT3/DNA inhibitors and methods of use
#226AURISTATIN TYRAMINE PHOSPHATE SALTS AND AURISTATIN AMINOQUINOLINE DERIVATIVES AND PRODRUGS THEREOF
#227Method of inhibiting activity of cell surface fibroblast activation protein alpha
#228Small molecule conjugates for intracellular delivery of biologically active compounds
#229Compositions and methods of using islet neogenesis peptides and analogs thereof
#230Substrate-mimetic AKT inhibitor
#231Synthetic peptide amides
#232Cytotoxic peptides and conjugates thereof
#233Peptides and combination of peptides for use in immunotherapy against various tumors
#234Peptides and combination of peptides for use in immunotherapy against various tumors
#235Peptides and combination of peptides for use in immunotherapy against various tumors
#236Peptides and combination of peptides for use in immunotherapy against various tumors
#237Peptides and combination of peptides for use in immunotherapy against various tumors
#238Peptides and combination of peptides for use in immunotherapy against various tumors
#239Peptides and combination of peptides for use in immunotherapy against various tumors
#240Peptides and combination of peptides for use in immunotherapy against various tumors
#241Antibacterial antisense oligonucleotide and method
#242Akt-specific capture agents, compositions, and methods of using and making
#243Protein-polymer-drug conjugates
#244Skin treatment devices and methods with pre-stressed configurations
#245Dichromic fluorescent compounds
#246NPR-B agonists
#247Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
#248Hydroxy-ethylene derivatives for the treatment of arthrosis
#249PEPTIDE NUCLEIC ACID PROBE (PNA), KIT AND METHOD FOR DETECTION OF ASPERGILLUS FUMIGATUS AND APPLICATIONS THEREOF
#250Template-directed γPNA synthesis process and γPNA targeting compounds
#251DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#252DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#253Hydrophilic self-immolative linkers and conjugates thereof
#254KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals
#255Methods for binding and precipitating gold using microbial-derived metallophores and their uses
#256Hydrophilic self-immolative linkers and conjugates thereof
#257Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
#258DENDRIMERIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
#259Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses
#260Azapeptides as CD36 binding compounds
#261SELF-STABILIZING LINKER CONJUGATES
#262Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#263Hepcidin mimetic peptides and uses thereof
#264Potent and efficient cytotoxic peptides and antibody-drug conjugates thereof and their synthesis
#265KETOAMIDE IMMUNOPROTEASOME INHIBITORS
#266Compositions and methods of using islet neogenesis peptides and analogs thereof
#267Synthetic peptide amides
#268Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
#269Uses of kappa opioid synthetic peptide amides
#270Peptide-oligourea chimeric compounds and methods of their use
#271Lysine oligomer derivative and cartilage tissue marker made thereof
#272Protein-polymer-drug conjugates
#273Processes for preparing tubulysin derivatives and conjugates thereof
#274Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus
#275Growth hormone releasing peptides
#276Site-specific chemoenzymatic protein modifications
#277Beta-hairpin peptidomimetics having CXCR4 antagonizing activity
#278Cytotoxic peptides and antibody drug conjugates thereof
#279Functional lipid constructs
#280Cell-penetrating peptides having a central hydrophobic domain
#281PROCESS FOR THE PREPARATION OF A VIRAL PROTEASE INHIBITOR AND INTERMEDIATES THEREOF
#282Method of making biologically active alpha-beta peptides
#283Akt-specific capture agents, compositions, and methods of using and making
#284PEPTIDOMIMETIC PROTEASE INHIBITORS
#285Activation of sodium potassium ATPase
#286Therapeutic compounds for immunomodulation
#287Solid oxidized glutathione salt and method for producing same
#288Inhibitors of viral integrase and methods of use
#289F11 receptor (F11R) antagonists as therapeutic agents
#290Glutathione analogs and uses thereof
#291Small molecule conjugates for intracellular delivery of biologically active compounds
#292Small molecule conjugates for intracellular delivery of nucleic acids
#293Modified Compstatin With Improved Stability And Binding Properties
#294Agonists and antagonists of the urotensinergic system
#295PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF
#296PROCESS FOR A FOLATE-TARGETED AGENT
#297Compositions for inhibiting virus entry and promoting virolysis, and methods thereof
#298Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
#299BIOSURFACE ENGINEERING
#300NPR-B agonists